Escitalopram: all 280 studies that test it
Page 3 of 3. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.
- Neurotrophic Factors and DepressionCompletedNCT00812994Phase 4
- Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDDCompletedNCT00785434Phase 4
- Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic DisorderCompletedNCT00767871Phase 4
- Treatment of Post-traumatic Stress Disorder With High Doses of EscitalopramCompletedNCT00736021Not applicable
- Comparison of Effects Between Conventional Dose and High Dose Escitalopram on Clinical Improvement in Patients With Obsessive-compulsive DisorderCompletedNCT00723060Phase 4
- Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label StudyStatus unknownNCT00708396Phase 4
- Treatment Youth With Obsessive-Compulsive DisorderStatus unknownNCT00708240Phase 4
- A Neuroimaging and Epigenetic Investigation of Antidepressants in DepressionCompletedNCT00703742Not applicable
- International Study to Predict Optimised Treatment - in DepressionStatus unknownNCT00693849Phase 4
- Validation of Surrogate Measures in Irritable Bowel Syndrome (IBS)CompletedNCT00693732Phase 4
- The Effect of Escitalopram on the Pharmacokinetics and Pharmacodynamics of Tramadol in Healthy SubjectsCompletedNCT00692263Phase 4
- Relapse Prevention With Escitalopram or Nortriptyline Following Electro-Convulsive Treatment (DUAG-7)TerminatedNCT00660062Phase 4
- Safety and Efficacy of Escitalopram in the Treatment of Premature EjaculationStatus unknownNCT00656552Early Phase 1
- Efficacy Study of Escitalopram for Depression in Patients With DiabetesStatus unknownNCT00650897Phase 4
- Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mgCompletedNCT00648661Phase 1
- Fasting Study of Escitalopram Oxalate Tablets 20 mg and Lexapro® Tablets 20 mgCompletedNCT00648570Phase 1
- Brain Mechanisms and Targeting Insomnia in Major DepressionStatus unknownNCT00628914Phase 4
- Behavioral Insomnia Therapy For Those With Insomnia and DepressionStatus unknownNCT00620789Not applicable
- Pharmacodynamics and Pharmacokinetics of Citalopram and EscitalopramCompletedNCT00613470Phase 1
- ERP N1 as a Treatment Predictor of Generalized Anxiety DisorderCompletedNCT00613067Not applicable
- Escitalopram (Lexapro®) In Patients With Major Depression With Atypical FeaturesCompletedNCT00610506Phase 3
- Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior TherapyStatus unknownNCT00598052Not applicable
- Escitalopram Treatment of Major Depression in Patients With Temporal Lobe EpilepsyCompletedNCT00595699Phase 4
- Efficacy of Escitalopram in the Treatment of Internet AddictionCompletedNCT00565422Phase 4
- Pharmacokinetic and Pharmacodynamic Effects of Escitalopram Depending on Genetic Polymorphisms of the ABCB1-geneCompletedNCT00550485Not applicable
- Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo NodularisStatus unknownNCT00532519Not applicable
- An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive DisorderCompletedNCT00531622Phase 3
- Childhood Adversity, Genetic Polymorphisms and Stress in First Onset Major DepressionCompletedNCT00517764Not applicable
- Escitalopram and Depression in Elderly Alzheimer's PatientsTerminatedNCT00488670Phase 3
- Flushing in Social Anxiety Disorder on CipralexCompletedNCT00485888Phase 2
- Escitalopram in Bipolar Depression: a Placebo-controlled Study of Acute and Maintenance TreatmentTerminatedNCT00464191Phase 4
- Escitalopram in Schizophrenia in OCD- Open Label StudyCompletedNCT00456937Phase 4
- Serotonin Transporter Genetic Variation and Amygdalar Activation Correlates of Antidepressant ResponseCompletedNCT00456430Phase 4
- Escitalopram and Sleep Architecture in Patients With Major Depressive DisorderStatus unknownNCT00442481Phase 4
- Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSDCompletedNCT00433121Phase 4
- Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive DisorderCompletedNCT00432614Phase 3
- Galantamine Augmentation of Escitalopram for Treatment of DepressionTerminatedNCT00423969Phase 4
- Escitalopram in Depressive Patients With Acute Coronary Artery SyndromeCompletedNCT00419471Phase 4
- Pupillary Changes as a Potential Biomarker for Escitalopram in Relation to CYP2C19 PolymorphismCompletedNCT00397059Phase 4
- Outcome Following Antidepressant Treatment on Possible Endo-Phenotypes for Major DepressionCompletedNCT00386841Phase 4
- Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed PatientsCompletedNCT00384436Phase 4
- Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant MedicationCompletedNCT00375843Phase 4
- Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.CompletedNCT00368862Phase 4
- Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD)CompletedNCT00305500Phase 3
- PTSD Prevention Using EscitalopramCompletedNCT00300313Not applicable
- Memory Functioning and Antidepressant TreatmentCompletedNCT00296933Phase 3
- Treatment of Depression Following Multiple Brain TestsCompletedNCT00296777Phase 4
- Are Two Antidepressants a Good Initial Treatment for Depression?CompletedNCT00296712Phase 4
- Lexapro in the Treatment of Patients With Postpartum DepressionCompletedNCT00277108Not applicable
- Treatment Resistant Bipolar DepressionTerminatedNCT00272025Phase 1
- Escitalopram Treatment of Patients With Agitated DementiaCompletedNCT00260624Phase 4
- DBT and Escitalopram in Borderline Personality DisorderStatus unknownNCT00255554Not applicable
- MOTIV Study- Effect of Antidepressive Treatment by Escitalopram in Patients Undergoing Coronary Artery Bypass GraftingCompletedNCT00243477Phase 4
- Escitalopram Combination Comparison Study for Adult Patients With Major Depressive DisorderStatus unknownNCT00239954Phase 3
- Medications for the Treatment of Dysthymic Disorder and Double DepressionCompletedNCT00234312Phase 4
- Investigation of a Combination Treatment of Escitalopram and rTMSCompletedNCT00232700Not applicable
- Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant SchizophreniaCompletedNCT00231335Phase 4
- Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's DementiaStatus unknownNCT00229333Phase 4
- Cipralex in Treatment of Depressive Symptoms and Chronic Back PainWithdrawnNCT00227292Phase 4
- Depression: The Search for Treatment-Relevant Phenotypes-Pilot StudyCompletedNCT00222820Phase 4
- A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant DepressionStatus unknownNCT00220480Not applicable
- Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive DisorderStatus unknownNCT00209807Phase 4
- Treatment Choices for Improving Adherence and OutcomeCompletedNCT00194948Not applicable
- Serotonin Transporter Inhibitor Escitalopram in Pulmonary HypertensionCompletedNCT00190333Phase 3
- Escitalopram as a Treatment for Pain in PolyneuropathyCompletedNCT00162968Phase 4
- Escitalopram as a Mood Stabilizer for Bipolar II DisorderCompletedNCT00156325Phase 2
- The Efficacy of Escitalopram for Negative Symptoms in SchizophreniaCompletedNCT00148447Phase 3
- Prevention of Post Traumatic Stress Disorder by Early TreatmentCompletedNCT00146900Not applicable
- DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary SyndromeStatus unknownNCT00140257Phase 4
- Prophylaxis of Psychiatric Symptoms During Anti-HCV TreatmentCompletedNCT00133276Phase 2/3
- Treatment of Depression in the ElderlyTerminatedNCT00130455Phase 4
- Study of Escitalopram in the Treatment of Specific PhobiaCompletedNCT00121069Phase 2/3
- Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)CompletedNCT00116532Phase 4
- Escitalopram for the Treatment of Self-Injurious Skin PickingCompletedNCT00115011Phase 4
- SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma VictimsTerminatedNCT00114374Phase 3
- Comparison of Escitalopram Combination in Adult Patients With Major Depressive DisorderCompletedNCT00109044Phase 3
- Study of Escitalopram in Adult Patients With Major Depressive DisorderCompletedNCT00108979Phase 3
- Treatment of Depression in AdultsCompletedNCT00073697Phase 4
- Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With DepressionCompletedNCT00073411Phase 3
- Preventing Post-Stroke DepressionCompletedNCT00071643Not applicable